Loading...
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study
OBJECTIVE: Primary platinum-resistant epithelial ovarian cancer (EOC) is an area of unmet medical need. There is limited evidence from small studies that platinum-based combinations can overcome “resistance” in a proportion of patients. We investigated the efficacy and toxicity of platinum-based com...
Na minha lista:
| Udgivet i: | Int J Gynecol Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485738/ https://ncbi.nlm.nih.gov/pubmed/25962114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IGC.0000000000000448 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|